Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty.
All companies · Product and company coverage
In the last ten years FDA made 12 decisions for Degen Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2025 (3). The latest was on 2025-12-08.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 14 |
| Cervical fusion & disc arthroplasty | 5 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-12-08 | 510(k) | K251829 | DeGen Medical Patient Specific Implant (PSI) System |
| 2025-10-10 | 510(k) | K252737 | DeGen Medical Latitude-C AM Cervical Interbody Fusion System |
| 2025-04-04 | 510(k) | K250667 | DeGen Medical Patient Specific Implant (PSI) System |
| 2024-10-29 | 510(k) | K241077 | DeGen Medical Patient Specific Implant (PSI) System |
| 2024-07-29 | 510(k) |
In 2025, Degen Medical reported engagement with 33 surgeons and other clinicians in the states MedaRep covers, worth $47K in consulting, speaking, meals and travel for its device products, the most in Texas ($23K to 13). Royalties are left out.
| K240326 |
| Solar Lumbar Interbody Fusion System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Degen Medical.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Texas ($23K, 13 engaged), North Carolina ($14K, 3 engaged), California ($3,655, 5 engaged), South Carolina ($3,343, 3 engaged), Georgia ($1,614, 1 engaged).